Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management - Journal of Obstetrics and Gynaecology Canada

Frontiers Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Disease: Current National and International Guidelines and the Need for Future Research

Improving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data

No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.

Guideline No. 441: Antenatal Fetal Health Surveillance - Journal of Obstetrics and Gynaecology Canada

Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management - ScienceDirect

1-s2 - Artículo de investigación - SOGC CLINICAL PRACTICE GUIDELINE No. 426, May 2022 (Replaces No. - Studocu

A Dormant Microbial Component in the Development of Pre-Eclampsia1

2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure - Journal of Cardiac Failure

FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction - Melamed - 2021 - International Journal of Gynecology

Guideline No. 402 Diagnosis and Management of Placenta Previa, PDF, Childbirth

Implementation of a home blood pressure monitoring program for the management of hypertensive disorders of pregnancy, an observational study in British Columbia, Canada - Karen C Tran, Sabina Freiman, Tessa Chaworth-Musters, Susan

Should Maternal Hemodynamics Guide Antihypertensive Therapy in Preeclampsia?